Source: Health Canada shortage reports · Updated Aug 18, 2026
Some Ivabradine products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 11, 2026.
A heart rate lowering medication used to treat heart failure.
Products affected
1 / 2
In shortage since
Aug 17, 2026
Est. full return
Sep 11, 2026
Reports on file
10
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
LANCORA
7.5MG · TABLET · SERVIER CANADA INC
DIN 02459981 · since Aug 17, 2026, est. end Sep 11, 2026 · Demand increase for the drug.
Resolved
LANCORA
5MG · TABLET · SERVIER CANADA INC
DIN 02459973 · ended Jul 24, 2026 · Delay in shipping of the drug.
Resolved
LANCORA
7.5MG · TABLET · SERVIER CANADA INC
DIN 02459981 · ended Jul 15, 2026 · Delay in shipping of the drug.
Resolved
LANCORA
5MG · TABLET · SERVIER CANADA INC
DIN 02459973 · ended Aug 28, 2025 · Delay in shipping of the drug.
Resolved
LANCORA
7.5MG · TABLET · SERVIER CANADA INC
DIN 02459981 · ended Oct 30, 2024 · Requirements related to complying with good manufacturing practices.
Resolved
LANCORA
5MG · TABLET · SERVIER CANADA INC
DIN 02459973 · ended Oct 16, 2024 · Delay in shipping of the drug.
Resolved
LANCORA
5MG · TABLET · SERVIER CANADA INC
DIN 02459973 · ended Sep 17, 2024 · Delay in shipping of the drug.
Resolved
LANCORA
5MG · TABLET · SERVIER CANADA INC
DIN 02459973 · ended Feb 21, 2024 · Higher than expected demand
Resolved
LANCORA
5MG · TABLET · SERVIER CANADA INC
DIN 02459973 · ended Nov 21, 2023 · Delay in shipping of the drug.
Resolved
LANCORA
5MG · TABLET · SERVIER CANADA INC
DIN 02459973 · ended Nov 2, 2023 · Delay in shipping of the drug.
What's happening
Ivabradine is currently affected by an active shortage report filed with Health Canada by SERVIER CANADA INC.
The reported cause is: demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Ivabradine is classified under “OTHER CARDIAC PREPARATIONS” (ATC C01EB).
Recent changes
Aug 18, 2026
New report filed
Jul 27, 2026
Shortage resolved
Jul 21, 2026
Shortage resolved
Jul 10, 2026
Estimated end date pushed back : Jul 10, 2026 → Jul 16, 2026
Common questions
What is Ivabradine used for?
A heart rate lowering medication used to treat heart failure.
When will Ivabradine be back in stock in Canada?
The latest manufacturer estimate is Sep 11, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Ivabradine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.